Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01360736 · ClinicalTrials.gov registry record · NA

A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans - Study 2 (SAFEMIL)

A NA study of Suicide and Suicide, Attempted, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

Completed
Registry status
NA
Development phase
102
Enrollment target
2
Study locations

NCT01360736 is a NA study of Suicide and Suicide, Attempted that has completed, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 102 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01360736, a NA study of Suicide and Suicide, Attempted, has completed, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

COMPLETED
Registry status
NA
Development phase
102 participants
Enrollment target
2
Study locations

Study Summary

The investigators propose to test the efficacy of a brief, readily accessible, and personalized treatment called the Safety Planning for Military (SAFE MIL; Stanley and Brown, 2012).

Interventions

  • BEHAVIORAL Safety Planning - Military (SAFE MIL)

Study Locations (2)

Maryland

  • Uniformed Services University of the Health Sciences - Bethesda
  • Walter Reed National Military Medical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2009-09
Est. Completion 2018-12
Phase NA

What the Registry Record Tells You About NCT01360736

The ClinicalTrials.gov registry entry for NCT01360736 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The listed sponsor is Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Safety Planning - Military (SAFE MIL) is the first listed.

NCT01360736 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01360736 about?

NCT01360736 is a clinical study titled "A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans - Study 2 (SAFEMIL)". The investigators propose to test the efficacy of a brief, readily accessible, and personalized treatment called the Safety Planning for Military (SAFE MIL; Stanley and Brown, 2012).

What is the current status of trial NCT01360736?

This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2009-09. Estimated completion is 2018-12.

What conditions does trial NCT01360736 study?

This clinical trial studies the following conditions: Suicide, Suicide, Attempted.

What interventions are being tested in trial NCT01360736?

The interventions under investigation include: Safety Planning - Military (SAFE MIL) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01360736?

This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01360736 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.